| Abstract | This is a clinical report of a 63-year-old woman, with a 3-year history of severe episodes of hypnic headache responding to low-doses of topiramate (25 mg at bedtime). Topiramate has been used at the dosage of 100 mg/day for hypnic headache prevention in one recent case report with benefit. This report confirms the efficacy of topiramate in hypnic headache even using low-dose regimen therapy. |
| Authors | Massimo Autunno, Corrado Messina, Anita Blandino, Carmelo Rodolico
(Affiliation: University of Messina, Department of Neurosciences, Psychiatry and Anaesthesiology, Messina, Italy.)
|
| Journal | Headache
(Headache)
Vol. 48
Issue 2
Pg. 292-4
(Feb 2008)
ISSN: 0017-8748 United States |
| PMID | 18081825
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
- Neuroprotective Agents
- Fructose
- topiramate
|
| Topics |
- Dose-Response Relationship, Drug
- Female
- Fructose
(analogs & derivatives, therapeutic use)
- Headache Disorders, Primary
(drug therapy)
- Humans
- Middle Aged
- Neuroprotective Agents
(therapeutic use)
|
